Janiczek Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$194K Sell
620
-107
-15% -$31.4K 0.04% 184
2024
Q1
$207K Sell
727
-30
-4% -$8.78K 0.04% 174
2023
Q4
$218K Buy
757
+61
+9% +$16.6K 0.05% 153
2023
Q3
$187K Buy
696
+377
+118% +$94.1K 0.05% 152
2023
Q2
$70.8K Sell
319
-103
-24% -$23.9K 0.02% 268
2023
Q1
$106K Buy
422
+118
+39% +$29K 0.03% 202
2022
Q4
$82.4K Buy
304
+77
+34% +$20.6K 0.02% 242
2022
Q3
$53K Sell
227
-218
-49% -$52.8K 0.02% 295
2022
Q2
$110K Sell
445
-36
-7% -$8.82K 0.03% 192
2022
Q1
$117K Buy
481
+243
+102% +$55.8K 0.03% 184
2021
Q4
$54K Sell
238
-201
-46% -$42.4K 0.02% 297
2021
Q3
$93K Sell
439
-5
-1% -$1.15K 0.03% 183
2021
Q2
$108K Sell
444
-24
-5% -$5.9K 0.04% 145
2021
Q1
$116K Buy
468
+168
+56% +$40.1K 0.05% 124
2020
Q4
$69K Buy
300
+236
+369% +$54.4K 0.03% 149
2020
Q3
$16K Buy
+64
New +$15.9K 0.01% 175

Other funds holding AMGN

Janiczek Wealth Management's AMGN Position: Q2 2024 in Review

Janiczek Wealth Management reduced its Amgen (AMGN) stake by 15% in Q2 2024, selling an estimated $31.4K and leaving 620 shares worth $194K. The position accounts for 0.04% of the portfolio, ranked #184.

Janiczek Wealth Management first reported a position in AMGN in Q3 2020 and has held it in 16 quarters since. The position peaked at $218K in Q4 2023. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • Janiczek Wealth Management held 620 shares of Amgen worth $194K as of Q2 2024.
  • Janiczek Wealth Management sold 107 Amgen shares in Q2 2024, an estimated $31.4K.
  • Amgen made up 0.04% of Janiczek Wealth Management's portfolio in Q2 2024, its #184 holding.
  • Janiczek Wealth Management first reported a position in Amgen in Q3 2020 and has held it in 16 quarters since.
  • Janiczek Wealth Management's Amgen position peaked at $218K in Q4 2023.
  • 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.